Form 4: Boston Scientific SVP, Global Controller and CAO, Emily Woodworth, Reports Changes in Beneficial Ownership

Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, reports transactions involving common stock and restricted stock units.

Summary

• On February 18, 2025, Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, filed a Form 4 detailing changes in beneficial ownership.
• The transactions include the acquisition and disposal of common stock related to the vesting of restricted stock units.
• Woodworth acquired 5,652 restricted stock units on February 13, 2025, and an option to purchase 5,732 shares of common stock.
• She also disposed of shares to cover tax obligations related to the vesting of restricted stock units on February 14, 16 and 17, 2025.
• The price for the disposed shares was $106.11.
• The restricted stock units will be issued in four equal annual installments beginning on the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation.

Positives

• The acquisition of restricted stock units and stock options indicates confidence in the company's future performance.

Future Outlook

The restricted stock units and stock options vest over several years, aligning the executive's interests with the long-term performance of the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.

Key Dates

Keywords

Form 4, beneficial ownership, Boston Scientific, BSX, restricted stock units, stock options, Emily Woodworth, SVP, Global Controller and CAO